PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma-Reference-Cited by-同舟云学术

PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma

Published:2020-12 Issue:6 Volume:30 Page:580-589
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:

Author:

Marcaillou Marion,Linder Clara,Chaltiel Léonor,Sibaud Vincent,Pagès Cécile,Modesto Anouchka,Chira Ciprian,Dalmasso Céline,Boulinguez Serge,Bedane Christophe,Meyer Nicolas

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference22 articles.

1. High frequency of brain metastases after adjuvant therapy for high-risk melanoma.;Samlowski;Cancer Med,2017

2. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.;Eggermont;Lancet Oncol,2015

3. Adjuvant pembrolizumab versus placebo in resected stage III Melanoma.;Eggermont;N Engl J Med,2018

4. Adjuvant therapy with nivolumab (NIVO) versus ipilimumab (IPI) after complete resection of stage III/IV melanoma: updated results from a phase III trial (CheckMate 238).;Weber;J Clin Oncol,2018

5. Melanoma central nervous system metastases: current approaches, challenges, and opportunities.;Cohen;Pigment Cell Melanoma Res,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-PD-1/PD-L1 inhibitor therapy for melanoma brain metastases: a systematic review and meta-analysis;Neurosurgical Review;2024-08-14

2. Cumulative incidence and risk factors of brain metastases in metastatic non–small cell lung cancer without baseline brain metastasis: Pooled analysis of individualized patient data from IMpower130, IMpower131, and IMpower150;Cancer;2024-02-14

3. Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG;Journal for ImmunoTherapy of Cancer;2023-04

4. Emerging Studies of Melanoma Brain Metastasis;Current Oncology Reports;2022-02-25

5. First line immunotherapy extends brain metastasis free survival, improves overall survival, and reduces the incidence of brain metastasis in patients with advanced melanoma;Cancer Reports;2021-06-17